Illumina Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Illumina Inc. (ILMN) shares rose 1.74% to $223.22, marking its fourth consecutive day of gains and a new 52-week high. The stock outperformed competitors Labcorp, Charles River Laboratories, and Quest Diagnostics during a mixed trading session where the Dow Jones rose slightly while the S&P 500 fell. Trading volume exceeded the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Illumina Inc. (ILMN) rallied 1.74% to $223.22 Monday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.26% to 53,417.16 and the S&P 500 Index falling 0.28% to 7,652.86.
This was the stock's fourth consecutive day of gains.
Illumina Inc. hit a new 52-week high, surpassing its previous peak of $220.43, which the company reached on August 21st.
The stock outperformed some of its competitors Monday, as Labcorp Holdings Inc. (LH) rose 0.89% to $339.34, Charles River Laboratories International Inc. (CRL) rose 1.15% to $298.58, and Quest Diagnostics Inc. (DGX) fell 0.21% to $243.87.
Trading volume (2.2 M) eclipsed its 50-day average volume of 1.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 24, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-24-26 1724ET